Fixing Healthcare Bottlenecks from First Principles: Interview with Enspectra Health CEO Gabriel Sanchez

Medsider: Learn from Medtech and Healthtech Founders and CEOs

#MBA #Entrepreneur #Business #Scott Nelson #Medtech #Medical Device #Healthcare #Healthtech #Regulatory #Reimbursement #Startup #Health Care #Med Tech #Health Tech

27:52

We made it— 300 episodes of This Is Woman’s Work ! And we’re marking this milestone by giving you something that could seriously change the game in your business or career: the skill of pitching yourself effectively. Whether you’re dreaming of being a podcast guest, landing a speaking gig, signing a client, or just asking for what you want with confidence—you’re already pitching yourself, every day. But are you doing it well? In this milestone episode, Nicole breaks down exactly how to pitch yourself to be a podcast guest … and actually hear “yes.” With hundreds of pitches landing in her inbox each month, she shares what makes a guest stand out (or get deleted), the biggest mistakes people make, and why podcast guesting is still one of the most powerful ways to grow your reach, authority, and influence. In This Episode, We Cover: ✅ Why we all need to pitch ourselves—and how to do it without feeling gross ✅ The step-by-step process for landing guest spots on podcasts (and more) ✅ A breakdown of the 3 podcast levels: Practice, Peer, and A-List—and how to approach each ✅ The must-haves of a successful podcast pitch (including real examples) ✅ How to craft a pitch that gets read, gets remembered, and gets results Whether you’re new to pitching or want to level up your game, this episode gives you the exact strategy Nicole and her team use to land guest spots on dozens of podcasts every year. Because your voice deserves to be heard. And the world needs what only you can bring. 🎁 Get the FREE Podcast Pitch Checklist + Additional Information on your Practice Group, Peer Group, and A-List Group Strategies: https://nicolekalil.com/podcast 📥 Download The Podcast Pitch Checklist Here Related Podcast Episodes: Shameless and Strategic: How to Brag About Yourself with Tiffany Houser | 298 How To Write & Publish A Book with Michelle Savage | 279 How To Land Your TED Talk and Skyrocket Your Personal Brand with Ashley Stahl | 250 Share the Love: If you found this episode insightful, please share it with a friend, tag us on social media, and leave a review on your favorite podcast platform! 🔗 Subscribe & Review: Apple Podcasts | Spotify | Amazon Music…

大约1年之前 27:01

MP3•单集首页

Gabriel holds a B.S. in mechanical engineering from MIT and an M.S. and Ph.D. from Stanford University, where he also served as an instructor in bioengineering and launched Enspectra to commercialize his groundbreaking research. VIO enables high-resolution, noninvasive imaging for skin cancer detection and health biometrics.

In this interview, Gabriel talks about his transition from academia to startups, how he narrowed down his idea to meet a pressing need in healthcare, the importance of speaking FDA’s language—or finding someone who does—and how he balances dilutive and non-dilutive funding.

Before we dive into the discussion, I wanted to mention a few things:

First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.

Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!

We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ lifescience investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!

In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, if you'd rather read than listen, here's a link to the full interview with Gabriel Sanchez.

199集单集

Fixing Healthcare Bottlenecks from First Principles: Interview with Enspectra Health CEO Gabriel Sanchez

Medsider: Learn from Medtech and Healthtech Founders and CEOs

published 大约1年之前

MP3•单集首页

Before we dive into the discussion, I wanted to mention a few things:

Lastly, if you'd rather read than listen, here's a link to the full interview with Gabriel Sanchez.

199集单集

#MBA #Entrepreneur #Business #Scott Nelson #Medtech #Medical Device #Healthcare #Healthtech #Regulatory #Reimbursement #Startup #Health Care #Med Tech #Health Tech

所有剧集

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
Building the Beachhead Strategy: Interview with Axena Health Leaders Randy Pritchard and Erica Rogers 55:01

8天之前55:01

55:01

In this episode of Medsider Radio , we sat down with Randy Pritchard and Erica Rogers , leaders of Axena Health . Axena is transforming pelvic floor therapy with Leva , a device bringing clinically-proven, supervised pelvic floor muscle training into women’s homes. Randy, CEO of Axena, brings nearly 25 years of healthcare experience to the company, most recently as CEO of Pillar Biosciences and previously holding leadership positions at Roche Diagnostics, where he spent 18 years developing commercial expertise. Erica, who sits on Axena's Board of Directors, spent a decade as President and CEO of Silk Road Medical, leading the company from early clinical trials through IPO and eventual acquisition by Boston Scientific. A returning guest to the podcast after nearly half a decade, Erica previously held roles at Medicine360, co-founded two other medical device companies, and spent over 12 years at Boston Scientific prior to her role at Silk Road. In this interview, they share essential medtech commercialization insights: identify your specific patient segment, build continuous clinical evidence, and communicate consistently with investors. Their experience offers invaluable lessons for medical device entrepreneurs navigating today's complex healthcare landscape. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Randy Pritchard and Erica Rogers.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
A Great Product vs. a Great Business: Interview with EDAP TMS CEO Ryan Rhodes 1:00:47

16天之前1:00:47

1:00:47

In this episode of Medsider Radio , we sat down with Ryan Rhodes , CEO of EDAP TMS . EDAP is changing prostate cancer treatment through Focal One, a robotic high-intensity focused ultrasound (HIFU) system that doesn’t require the use of surgery or radiation. Ryan has over 30 years of experience in market development, with two decades focused on medical robotics. Before EDAP, Ryan was CEO of Restoration Robotics, where he guided the company to a successful merger with Venus Concept. He spent 13+ years at Intuitive Surgical, establishing the global Urology franchise, which became the company’s entry point for broader adoption of the da Vinci system. He also spent 11 years at Ethicon (J&J) in sales, marketing, and market development. In this interview, Ryan challenges founders to ask: Are you creating a scalable medtech solution or a product with limited growth potential? He unpacks why standardization and scalability are critical for adoption, how clinical data fuels credibility and reimbursement, and why early adopters take the biggest risks — but also reap the biggest rewards. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Ryan Rhodes.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
The Hard Truth About Partnerships: Interview with Vivos CEO Kirk Huntsman 1:03:36

22天之前1:03:36

1:03:36

In this episode of Medsider Radio , we sat down with Kirk Huntsman , CEO of Vivos , a company commercializing a non-invasive, FDA-cleared oral appliance designed to treat obstructive sleep apnea (OSA). Kirk is a seasoned healthcare entrepreneur with a track record for scaling and exiting successful businesses. He founded Dental One, growing it into one of the largest dental service organizations (DSO) in the U.S., with over 165 practices across 15 states. After selling the company to MSD Capital, he led ReachOut Healthcare America, a Morgan Stanley Private Equity portfolio company. He later built and exited Xenith Practices, another DSO, and founded Ortho Ventures, focusing on pediatric oral appliances. Now as CEO of Vivos, Kirk and his team are developing and commercializing proprietary treatments for sleep-related breathing disorders, offering patients an FDA-cleared alternative to CPAP therapy. In this interview, Kirk talks about his go-to-market strategy, the importance of credibility markers, the complexity of industry partnerships, and the challenges he faced pursuing an IPO. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Kirk Huntsman.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
Is Your Medtech Idea Worth Pursuing?: Interview with BrainSpace CEO Caitlin Morse 1:01:28

5 weeks之前1:01:28

1:01:28

In this episode of Medsider Radio , we sat down with Caitlin Morse , CEO and co-founder of BrainSpace , who has a decade of experience spanning medtech consulting, product development, and strategic advising. BrainSpace is developing an innovative precision drainage system with continuous ICP monitoring designed to automate cerebrospinal fluid management for patients recovering from strokes, traumatic brain injuries, and neurosurgery. In this interview, Caitlin shares her advice on assessing the viability of a medtech idea, tells the story of how her prototype won over stakeholders, and discusses navigating the development phase while balancing clinical and regulatory demands. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Caitlin Morse.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
How to Succeed Without Venture Capital: Interview with Front Line Medical Co-Founders Drs. Asha Parekh and Adam Power 1:04:51

6 weeks之前1:04:51

1:04:51

In this episode of Medsider Radio , we had an insightful discussion with Drs. Asha Parekh and Adam Power , co-founders of Front Line Medical Technologies . The company's COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System) is a compact, minimally invasive device, designed for temporary aortic occlusion in trauma situations. Asha has a PhD in Biomedical Engineering from Western University, and combines technical expertise with entrepreneurial leadership. Adam is an academic and practicing vascular surgeon at Western University, with extensive training from institutions including Dalhousie, McMaster, and Mayo Clinic. In this interview, they discuss how their clinical-engineer partnership accelerated development, their approach to clinical studies for regulatory clearance across multiple geographies, and their strategic decision to avoid VC funding during early development—and how that decision paid off. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Asha Parekh and Adam Power.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
Why Your 'Kitty Hawk Moment' Matters: Interview with Elucid CEO Kelly Huang 48:09

7 weeks之前48:09

48:09

In this episode of Medsider Radio , we sat down with Kelly Huang , President and CEO of Elucid . Elucid has developed a platform that uses AI to analyze cardiac CT scans to provide a detailed, non-invasive assessment of a patient’s arterial plaque. Kelly's journey spans nearly 30 years of leadership in healthcare, with expertise in driving innovation and growth across medical devices, diagnostics, health IT, and consumer health. Before Elucid, he served as COO at Cardea Bio, leading its successful acquisition by Paragraf, and as CEO of Obalon Therapeutics, where he introduced noninvasive medical devices to expand treatment options for physicians. Kelly's career also includes senior roles at L-Nutra, Nestlé/Galderma, Endo Pharmaceuticals, and Johnson & Johnson. In this interview, Kelly shares advice on how to successfully bring novel devices to market, secure reimbursement, and drive adoption by focusing on the essentials—collaboration, trust, robust data, and transparency. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Kelly Huang.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
De-Risk and Execute to Create Value: Interview with Supira Medical CEO Nitin Salunke, PhD 18:20

8 weeks之前18:20

18:20

In this episode of Medsider Radio , we had an insightful chat with Nitin Salunke , President and CEO of Supira Medical , a Shifamed portfolio company. Supira is developing a catheter-based heart pump that provides hemodynamic support for patients undergoing high-risk heart procedures. Before Supira, Nitin was Vice President of R&D at Medtronic Neurovascular, overseeing global product development. He has also held leadership roles at Altura Medical, Cordis Corp (then a Johnson & Johnson company), and W.L. Gore & Associates. Nitin holds a PhD in Mechanical Engineering and is an inventor and co-author on many patents and publications. In this interview, Nitin shares the philosophy that guided his journey as CEO of Supira, his strategy to evaluate and address major risk factors in medtech, how to generate value for all stakeholders—patients, physicians, and investors, and his formula for creating a next-gen medical device. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Nitin Salunke.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
Two Stakeholders You Can’t Ignore: Interview with Tioga CEO Mike Dineen 26:03

9 weeks之前26:03

26:03

In this episode of Medsider Radio , we sat down with Mike Dineen , co-founder and CEO of Tioga Cardiovascular , a Shifamed portfolio company. Tioga is developing a minimally invasive transcatheter mitral valve replacement (TMVR) device to address mitral regurgitation (MR) - a condition where blood flows backward into the heart, often causing heart failure. Mike has 30 years of experience in leading and scaling innovative medical device startups, and is co-inventor on more than 65 patents. His track record encompasses leadership roles at Kalila Medical (acquired by Abbott and later divested to Terumo), Maya Medical (acquired by Covidien), and Aspire Medical (acquired by Philips/Respironics). In this interview, Mike discusses why engaging with physicians early is essential and what he prioritizes in those conversations, the importance of pushing for early pre-clinical testing and how to best approach it, and his strategy for raising capital by targeting early-stage investors with a clear, exit-focused plan. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Mike Dineen.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
How to Validate Your Idea Rigorously: Interview with Flow Medical CEO Jennifer Fried 26:17

9 weeks之前26:17

26:17

In this episode of Medsider Radio , we sat down with Jennifer Fried , co-founder and CEO of Flow Medical . Her startup is developing an advanced catheter designed to treat pulmonary embolisms. Jennifer started her career as a healthcare venture capitalist and consultant at Bain & Company. Before co-founding Flow Medical, Jennifer was the CEO and co-founder of ExplORer Surgical, a surgical software platform spun out of research at The University of Chicago. Under her leadership, ExplORer grew from an idea to a global product, earning accolades, like being named one of the Top 50 Healthcare Technology CEOs, and partnerships with major medical device companies. Jennifer successfully exited the business in 2021, when it was acquired by GHX. In this interview, Jennifer shares insights on navigating M&As, raising capital, and tips for validating ideas. She explains why engaging early with potential acquirers is key, how challenging your assumptions can save years of effort, and the importance of tailoring your pitch and building lasting investor relationships. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Jennifer Fried.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
Who’s Paying for It?: Interview with Aclarion CEO Brent Ness 26:43

13 weeks之前26:43

26:43

In this episode of Medsider Radio , we sat down with Brent Ness , President and CEO of Aclarion , a startup developing a decision-support tool designed to improve the diagnosis and treatment of chronic low back pain. Brent has over 28 years of experience in medtech. Before Aclarion, he led Cleerly as President & CCO, driving the adoption of their AI cardiology solution through strategic partnerships. As COO of Mighty Oak Medical, he guided their FIREFLY spine navigation platform from FDA clearance to international launch. At HeartFlow, Brent spearheaded the global expansion of their image-based SaaS solution, and at Medtronic, he led the acquisition and rollout of the O-Arm technology. His career also includes leadership roles at GE Healthcare, Philips North America, and ProNerve. In this interview, Brent shares his approach to reimbursement, why continuing to prove your technology is crucial (even after regulatory approval), and how to effectively engage with KOLs for optimal support. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Brent Ness.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
Think Commercially from Day One: Interview with Conformal Medical CEO James Reinstein 25:58

14 weeks之前25:58

25:58

In this episode of Medsider Radio , we sat down with James Reinstein , President and CEO of Conformal Medical , a company developing a foam device that seals the left atrial appendage (LAA) to reduce the risk of stroke without anticoagulants. James has over 30 years of experience in the medical device industry. He’s held executive roles across multiple companies, including Saranas, Cutera, Drawbridge Health, and Aptus Endosystems (acquired by Medtronic). Earlier in his career, he served as Senior VP and Chief Commercial Officer at Cyberonics (now LivaNova) and as Vice President of Boston Scientific’s Asia region. In this interview, James discusses choosing the right market, simplifying workflows to drive adoption, and balancing clinical focus with early commercialization planning. He also offers fundraising insights, including planning for long-term events like IPOs. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with James Reinstein.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
Maximize Market Opportunity, Minimize Feedback Loops: Interview with SAVA Co-founders Rafaël Michali and Renato Circi 28:53

15 weeks之前28:53

28:53

In this episode of Medsider Radio , we had a great chat with Rafaël Michali and Renato Circi , co-founders of SAVA , a London-based biotechnology startup developing a novel biosensing platform to monitor molecules just below the skin in real time. Rafaël and Renato are biomedical engineers from Imperial College London. Both recognized in the Forbes 30 Under 30 list as some of Europe’s most promising young innovators in 2018, the duo raised $13M in funding and built a cross-functional team of now over 40 to develop a next-generation biosensing platform. Together, they built a thesis surrounding preventative health, from which SAVA was formed: redefining healthcare into a system that is accessible, personalized, and preventative. In this interview, they talk about the value of identifying a large market with substantial opportunity, how they moved rapidly through development iterations, the right time to exit stealth mode, and the complexities of building a medical device. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Rafaël Michali and Renato Circi.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
Fixing Healthcare Bottlenecks from First Principles: Interview with Enspectra Health CEO Gabriel Sanchez 27:01

18 weeks之前27:01

27:01

In this episode of Medsider Radio , we sat down with Gabriel Sanchez , co-founder and CEO of Enspectra Health . The company's flagship VIO platform is the first FDA-cleared imaging modality for dermatology in over 25 years. Gabriel holds a B.S. in mechanical engineering from MIT and an M.S. and Ph.D. from Stanford University, where he also served as an instructor in bioengineering and launched Enspectra to commercialize his groundbreaking research. VIO enables high-resolution, noninvasive imaging for skin cancer detection and health biometrics. In this interview, Gabriel talks about his transition from academia to startups, how he narrowed down his idea to meet a pressing need in healthcare, the importance of speaking FDA’s language—or finding someone who does—and how he balances dilutive and non-dilutive funding. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ lifescience investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Gabriel Sanchez.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
Low Drama, High Performance, Big Results: Interview with PhotoniCare CEO Cary Vance 24:58

19 weeks之前24:58

24:58

In this episode of Medsider Radio , we sat down with Cary Vance , CEO of PhotoniCare . The company's FDA-cleared OtoSight™ Middle Ear Scope is a clinical diagnostic tool that offers a non-invasive and comprehensive assessment of middle ear fluid. Cary is a proven medtech leader with over two decades of experience across large strategics like GE Healthcare and Covidien, and nearly 11 years as CEO of six different startups, including Titan Medical and Hansen Medical where he drove commercialization, fundraising, and M&A opportunities. He's been the Chairman, President, and CEO of PhotoniCare since May 2023. In this interview, Cary shares why clinical evidence, workflow efficiency, and financial viability are the three pillars of medtech success and how he prepares for launches and M&As from day one. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership . You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more! We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks , which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ lifescience investors more efficiently for your fundraise and help you discover your next medical device or health technology investor! In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more. Lastly, if you'd rather read than listen, here's a link to the full interview with Cary Vance.…

Medsider: Learn from Medtech and Healthtech Founders and CEOs

1
Execution Beats Flashy Funding: Interview with AccurKardia CEO Juan C. Jimenez 24:20

20 weeks之前24:20